(Total Views: 606)
Posted On: 04/25/2021 1:34:26 PM
Post# of 84295
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Something interesting someone pointed out to me this past week.....
UNIVERSITY OF MARYLAND HAS BECOME one of the top Universities for research so for Bioremedies and Dr Dalton to be working with them is HUGE. Thats a lot bigger deal then people realize. AND FOR DOC TO BE ON BOARD OF DIRECTORS IS HUGE IN ITSELF.
https://today.umd.edu/articles/research-ranki...cal%20year
https://www.umbiopark.com/news-events/news/47...-potential
https://www.umbiopark.com/biopark/park-leadership
UNIVERSITY OF MARYLAND HAS BECOME one of the top Universities for research so for Bioremedies and Dr Dalton to be working with them is HUGE. Thats a lot bigger deal then people realize. AND FOR DOC TO BE ON BOARD OF DIRECTORS IS HUGE IN ITSELF.
Quote:
Widely recognized as the preeminent measure for higher education institutions engaged in sponsored research, the HERD ranking pushes the University of Maryland into an elite tier in terms of funding—eighth in research and development spending among public institutions and 14th among all U.S. universities in fiscal year 2019. For 2018, UMD and UMB ranked 47th and 55th respectively.
“Through the University of Maryland Strategic Partnership, the University of Maryland has become a world-class research enterprise—one with the power, depth and reach to discover knowledge, innovations and technologies,” said University of Maryland, College Park President Darryll J. Pines. “These advances are vital to meeting the challenges facing our world, including the COVID-19 pandemic, climate change, and racial, economic and health care injustice.”
https://today.umd.edu/articles/research-ranki...cal%20year
Quote:
Baltimore, MD (June 3, 2020) - A team led by the Ciaran Skerry, Ph.D., assistant professor of microbiology and immunology at the University of Maryland School of Medicine, partnered with bioRemedies MD to launch a pre-clinical study this week to examine whether cannabinoids (CBD) has anti-viral effects on cells infected with the COVID-19 virus in the laboratory. The researchers are utilizing a proprietary, custom-blended CBD formulated and produced by bioRemedies MD to understand the cannabinoid interactions surrounding respiratory diseases.
https://www.umbiopark.com/news-events/news/47...-potential
https://www.umbiopark.com/biopark/park-leadership
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)